Drug design, development and therapy - JoVE Visualize

Showing results (1391-1400 of 5,682) with videos related to

Pageof 569

Sort By:

Drug Design, Development and Therapy|September 10, 2026

Matrine Alleviates Sepsis-Induced Acute Lung Injury by Reinforcing NQO1/SLC7A11/GPX4-Associated Anti-Ferroptotic Defenses and Attenuating NF-κB-Driven InflammationXue Chen, Min Yuan, Ting Huang, et al.

Drug Design, Development and Therapy|September 10, 2026

Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo AssessmentsSandra Megantara, Rohani Rohani, M Rahmatullah Zakaria, et al.

Drug Design, Development and Therapy|September 9, 2026

First-in-Human Phase I Trial of HRS-2129, a Selective Nav1.8 Inhibitor: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsJie Huang, Qian Wu, Saiying Wang, et al.

Drug Design, Development and Therapy|September 16, 2026

Effects of an Ultrasound‑Guided Femoral, Sciatic, and Genitofemoral Nerve Block with Ropivacaine on EC5 0 and EC9 5 for High Saphenous Vein LigationHui Wang, Jiangtao Chang, Yufei Li, et al.

Drug Design, Development and Therapy|September 8, 2026

The Evolving Landscape of Hepatocellular Carcinoma Therapy: From Conventional Modalities to TME-Responsive Prodrug Design StrategiesJiayao Chen, Hongrui Yan, Haoyu Wang, et al.

Drug Design, Development and Therapy|September 9, 2026

Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical TrialXiaoying Cui, Wutao Chen, Jinyu Wang, et al.

Drug Design, Development and Therapy|September 14, 2026

Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and SafetyLuisa Costa, Francesco Caso, Francesco Maione, et al.

Drug Design, Development and Therapy|September 14, 2026

Integrated Transcriptomic and Proteomic Analysis Elucidates the Mechanisms of Huperzine A Injection Against Cerebral Ischemia/Reperfusion InjuryYule Wang, Li Xie, Yue Gao

Drug Design, Development and Therapy|September 13, 2026

Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's DiseaseYu-Qing Guo, Yi-Ting Wang, Min Gao, et al.

Drug Design, Development and Therapy|September 19, 2026

Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future PerspectivesXiaonan Liang, Ping Jin, Yan Xue, et al.

Pageof 569

Showing results (1391-1400 of 5,682) with videos related to

Sort By:

Pageof 569

Drug Design, Development and Therapy|September 10, 2026

Matrine Alleviates Sepsis-Induced Acute Lung Injury by Reinforcing NQO1/SLC7A11/GPX4-Associated Anti-Ferroptotic Defenses and Attenuating NF-κB-Driven InflammationXue Chen, Min Yuan, Ting Huang, et al.

Drug Design, Development and Therapy|September 10, 2026

Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo AssessmentsSandra Megantara, Rohani Rohani, M Rahmatullah Zakaria, et al.

Drug Design, Development and Therapy|September 9, 2026

First-in-Human Phase I Trial of HRS-2129, a Selective Nav1.8 Inhibitor: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsJie Huang, Qian Wu, Saiying Wang, et al.

Drug Design, Development and Therapy|September 16, 2026

Effects of an Ultrasound‑Guided Femoral, Sciatic, and Genitofemoral Nerve Block with Ropivacaine on EC5 0 and EC9 5 for High Saphenous Vein LigationHui Wang, Jiangtao Chang, Yufei Li, et al.

Drug Design, Development and Therapy|September 8, 2026

The Evolving Landscape of Hepatocellular Carcinoma Therapy: From Conventional Modalities to TME-Responsive Prodrug Design StrategiesJiayao Chen, Hongrui Yan, Haoyu Wang, et al.

Drug Design, Development and Therapy|September 9, 2026

Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical TrialXiaoying Cui, Wutao Chen, Jinyu Wang, et al.

Drug Design, Development and Therapy|September 14, 2026

Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and SafetyLuisa Costa, Francesco Caso, Francesco Maione, et al.

Drug Design, Development and Therapy|September 14, 2026

Integrated Transcriptomic and Proteomic Analysis Elucidates the Mechanisms of Huperzine A Injection Against Cerebral Ischemia/Reperfusion InjuryYule Wang, Li Xie, Yue Gao

Drug Design, Development and Therapy|September 13, 2026

Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's DiseaseYu-Qing Guo, Yi-Ting Wang, Min Gao, et al.

Drug Design, Development and Therapy|September 19, 2026

Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future PerspectivesXiaonan Liang, Ping Jin, Yan Xue, et al.

Pageof 569